IDEAS home Printed from https://ideas.repec.org/a/nat/natcom/v13y2022i1d10.1038_s41467-022-34244-2.html
   My bibliography  Save this article

Variant-specific symptoms of COVID-19 in a study of 1,542,510 adults in England

Author

Listed:
  • Matthew Whitaker

    (Imperial College London
    Imperial College London)

  • Joshua Elliott

    (Imperial College Healthcare NHS Trust
    Imperial College London)

  • Barbara Bodinier

    (Imperial College London
    Imperial College London)

  • Wendy Barclay

    (Imperial College London)

  • Helen Ward

    (Imperial College Healthcare NHS Trust
    Imperial College London
    National Institute for Health Research Imperial Biomedical Research Centre)

  • Graham Cooke

    (Imperial College Healthcare NHS Trust
    Imperial College London
    National Institute for Health Research Imperial Biomedical Research Centre)

  • Christl A. Donnelly

    (Imperial College London
    Imperial College London
    University of Oxford)

  • Marc Chadeau-Hyam

    (Imperial College London
    Imperial College London)

  • Paul Elliott

    (Imperial College London
    Imperial College London
    Imperial College Healthcare NHS Trust
    National Institute for Health Research Imperial Biomedical Research Centre)

Abstract

Infection with SARS-CoV-2 virus is associated with a wide range of symptoms. The REal-time Assessment of Community Transmission −1 (REACT-1) study monitored the spread and clinical manifestation of SARS-CoV-2 among random samples of the population in England from 1 May 2020 to 31 March 2022. We show changing symptom profiles associated with the different variants over that period, with lower reporting of loss of sense of smell or taste for Omicron compared to previous variants, and higher reporting of cold-like and influenza-like symptoms, controlling for vaccination status. Contrary to the perception that recent variants have become successively milder, Omicron BA.2 was associated with reporting more symptoms, with greater disruption to daily activities, than BA.1. With restrictions lifted and routine testing limited in many countries, monitoring the changing symptom profiles associated with SARS-CoV-2 infection and effects on daily activities will become increasingly important.

Suggested Citation

  • Matthew Whitaker & Joshua Elliott & Barbara Bodinier & Wendy Barclay & Helen Ward & Graham Cooke & Christl A. Donnelly & Marc Chadeau-Hyam & Paul Elliott, 2022. "Variant-specific symptoms of COVID-19 in a study of 1,542,510 adults in England," Nature Communications, Nature, vol. 13(1), pages 1-10, December.
    • Handle: RePEc:nat:natcom:v:13:y:2022:i:1:d:10.1038_s41467-022-34244-2
    DOI: 10.1038/s41467-022-34244-2
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/s41467-022-34244-2
    File Function: Abstract
    Download Restriction: no
    File URL: https://libkey.io/10.1038/s41467-022-34244-2?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Michael C Grant & Luke Geoghegan & Marc Arbyn & Zakaria Mohammed & Luke McGuinness & Emily L Clarke & Ryckie G Wade, 2020. "The prevalence of symptoms in 24,410 adults infected by the novel coronavirus (SARS-CoV-2; COVID-19): A systematic review and meta-analysis of 148 studies from 9 countries," PLOS ONE, Public Library of Science, vol. 15(6), pages 1-19, June.
    2. Oliver Eales & Leonardo Oliveira Martins & Andrew J. Page & Haowei Wang & Barbara Bodinier & David Tang & David Haw & Jakob Jonnerby & Christina Atchison & Deborah Ashby & Wendy Barclay & Graham Taylo, 2022. "Dynamics of competing SARS-CoV-2 variants during the Omicron epidemic in England," Nature Communications, Nature, vol. 13(1), pages 1-11, December.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Najeeb Ullah & Khurshid Ahmad Khan & Javeid Iqbal & Asim Rana & Bilal Bin Younis & Mohsin Asif & Aijaz Zeeshan Khan Chachar & Falak shan, 2020. "Efficacy of Remdesivir in Covid-19 Patients; Multicenter Study in Lahore," International Journal of Sciences, Office ijSciences, vol. 9(11), pages 31-34, November.
    2. Oliver Viera-Segura & Natali Vega-Magaña & Mariel García-Chagollán & Marcela Peña-Rodríguez & Germán Muñoz-Sánchez & Ahtziri Socorro Carranza-Aranda & Iris Monserrat Llamas-Covarrubias & Moisés Ramos-, 2021. "A Comprehensive Descriptive Epidemiological and Clinical Analysis of SARS-CoV-2 in West-Mexico during COVID-19 Pandemic 2020," IJERPH, MDPI, vol. 18(20), pages 1-13, October.
    3. Caterina Alacevich & Inna Thalmann & Catia Nicodemo & Simon Lusignan & Stavros Petrou, 2023. "Symptomatic SARS-CoV-2 Episodes and Health-Related Quality of Life," Applied Health Economics and Health Policy, Springer, vol. 21(5), pages 761-771, September.
    4. Abbasi-Kangevari, Mohsen & Ghanbari, Ali & Malekpour, Mohammad-Reza & Ghamari, Seyyed-Hadi & Azadnajafabad, Sina & Saeedi Moghaddam, Sahar & Keykhaei, Mohammad & Haghshenas, Rosa & Golestani, Ali & Ra, 2023. "Exploring the clinical benefit of ventilation therapy across various patient groups with COVID-19 using real-world data," Open Access Publications from Kiel Institute for the World Economy 273506, Kiel Institute for the World Economy (IfW Kiel).
    5. Bo Zhao & Fanlei Kong & Myo Nyein Aung & Motoyuki Yuasa & Eun Woo Nam, 2020. "Novel Coronavirus (COVID-19) Knowledge, Precaution Practice, and Associated Depression Symptoms among University Students in Korea, China, and Japan," IJERPH, MDPI, vol. 17(18), pages 1-17, September.
    6. Ighor Arantes & Gonzalo Bello & Valdinete Nascimento & Victor Souza & Arlesson Silva & Dejanane Silva & Fernanda Nascimento & Matilde Mejía & Maria Júlia Brandão & Luciana Gonçalves & George Silva & C, 2023. "Comparative epidemic expansion of SARS-CoV-2 variants Delta and Omicron in the Brazilian State of Amazonas," Nature Communications, Nature, vol. 14(1), pages 1-15, December.
    7. Nikola Anđelić & Sandi Baressi Šegota & Ivan Lorencin & Zdravko Jurilj & Tijana Šušteršič & Anđela Blagojević & Alen Protić & Tomislav Ćabov & Nenad Filipović & Zlatan Car, 2021. "Estimation of COVID-19 Epidemiology Curve of the United States Using Genetic Programming Algorithm," IJERPH, MDPI, vol. 18(3), pages 1-26, January.
    8. Carol Nash, 2020. "Report on Digital Literacy in Academic Meetings during the 2020 COVID-19 Lockdown," Challenges, MDPI, vol. 11(2), pages 1-24, September.
    9. Nguyen, My, 2020. "Mask Mandates and COVID-19 Related Symptoms in the US," MPRA Paper 109992, University Library of Munich, Germany.
    10. Laurent Gerbaud & Candy Guiguet-Auclair & Franck Breysse & Joséphine Odoul & Lemlih Ouchchane & Jonathan Peterschmitt & Camille Dezfouli-Desfer & Vincent Breton, 2020. "Hospital and Population-Based Evidence for COVID-19 Early Circulation in the East of France," IJERPH, MDPI, vol. 17(19), pages 1-17, September.
    11. Erika Christina Gouveia e Silva & Ana Carolina Basso Schmitt & Caroline Gil de Godoy & Danielle Brancolini de Oliveira & Clarice Tanaka & Carlos Toufen & Carlos Roberto Ribeiro de Carvalho & Celso R. , 2023. "Risk Factors for the Impairment of Ambulation in Older People Hospitalized with COVID-19: A Retrospective Cohort Study," IJERPH, MDPI, vol. 20(22), pages 1-10, November.
    12. Arthur Eumann Mesas & Iván Cavero-Redondo & Celia Álvarez-Bueno & Marcos Aparecido Sarriá Cabrera & Selma Maffei de Andrade & Irene Sequí-Dominguez & Vicente Martínez-Vizcaíno, 2020. "Predictors of in-hospital COVID-19 mortality: A comprehensive systematic review and meta-analysis exploring differences by age, sex and health conditions," PLOS ONE, Public Library of Science, vol. 15(11), pages 1-23, November.
    13. Marcin Januszewski & Laura Ziuzia-Januszewska & Alicja A. Jakimiuk & Waldemar Wierzba & Anna Gluszko & Joanna Zytynska-Daniluk & Artur J. Jakimiuk, 2021. "Is the Course of COVID-19 Different during Pregnancy? A Retrospective Comparative Study," IJERPH, MDPI, vol. 18(22), pages 1-15, November.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:13:y:2022:i:1:d:10.1038_s41467-022-34244-2. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.